Deal Details

TLGY Completes $230 Million IPO

Healthcare

TLGY IPO

Summary

TLGY Acquisition Corporation (“TLGY” or the “Company”), a special purpose acquisition company, recently completed an upsized initial public offering of 23,000,000 units, including the exercise in full of the underwriters' option to purchase an additional 3,000,000 units, at a price of $10.00 per unit, generating gross proceeds of $230 million. The Company intends to use the net proceeds from this offering to effect a future business combination.

Baird served as lead manager on this offering.

About

TLGY is a blank check company incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. While the Company may pursue an acquisition or business combination target in any business or industry, it intends to focus its search on the global biopharma or technology enabled business-to-consumer (“B2C”) industries. TLGY is led by Jin-Goon Kim, a former partner of TPG Capital and a former CEO of industry leaders in Asia, including Dell Korea and Li Ning. Jin-Goon Kim is joined by Co-Presidents, Dr. Theron Odlaug, who has more than 40 years of experience as a CEO, Board Member and Senior Executive of pharmaceutical and allied companies, and Steven Norman, who has more than 20 years of experience as an executive and a director in the Asia-Pacific technology space.

Healthcare

TLGY IPO